Bellotti V, Arosio P, Cazzola M, Cozzi A, Levi S, Meloni F, Zoppone E
Br J Haematol. 1987 Apr;65(4):489-93. doi: 10.1111/j.1365-2141.1987.tb04156.x.
The ferritin present in human serum differs from the ferritins found in tissues and other body fluids in having negligible proportions of H subunits. This has been related to the possible presence of binding factors which would form complexes with H-subunit containing ferritins and thereby determine their rapid clearance and/or interference with immunoassays ('serum inhibition'). In this work we have tried to identify and characterize these binding factors. Dotting and blotting experiments demonstrated an interaction between tissue ferritins and human serum. This was stronger with human heart and recombinant H-type ferritin obtained from E. coli than with human liver ferritin. The serum binder appeared to be a glycoprotein migrating in the beta-2 region and with a molecular weight of about 200,000 and pI between 4 and 5. Two different approaches to purification of the ferritin-binding protein yielded enriched fractions containing also the complement proteins C3 and C4, the plasma protease inhibitor alpha-2-macroglobulin, and immunoglobulins. These in vitro findings may have physiological relevance.
人血清中的铁蛋白与组织及其他体液中的铁蛋白不同,其H亚基的比例可忽略不计。这可能与结合因子的存在有关,这些结合因子会与含H亚基的铁蛋白形成复合物,从而决定它们的快速清除和/或对免疫测定的干扰(“血清抑制”)。在这项研究中,我们试图鉴定并表征这些结合因子。斑点和印迹实验证明了组织铁蛋白与人血清之间的相互作用。与人心肌和从大肠杆菌获得的重组H型铁蛋白相比,这种相互作用与人肝铁蛋白的相互作用更强。血清结合剂似乎是一种糖蛋白,在β-2区域迁移,分子量约为200,000,pI在4至5之间。两种不同的纯化铁蛋白结合蛋白的方法得到了富集组分,其中还含有补体蛋白C3和C4、血浆蛋白酶抑制剂α-2-巨球蛋白和免疫球蛋白。这些体外研究结果可能具有生理学意义。